Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose-Mario Capo-Chichi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pathology|June 6, 2019
Emerging patterns in clonal haematopoiesisJose-Mario Capo-Chichi, Phillip Michaels, Rosemarie Tremblay-Le May, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell TransplantationGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Human Pathology|August 18, 2020
Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcomeGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Bioinformatics (Oxford, England)|February 12, 2022
SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived dataJessie J F Medeiros, Jose-Mario Capo-Chichi, Liran I Shlush, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
The Clinical Utility of <i>FLT3</i> Mutation Testing in Acute Leukemia: A Canadian ConsensusJulie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, et al.
The Journal of Pathology. Clinical Research|November 3, 2018
Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluationAoife J McCarthy, Jose-Mario Capo-Chichi, Tara Spence, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Plos Genetics|October 31, 2014
De novo mutations in moderate or severe intellectual disabilityFadi F Hamdan, Myriam Srour, Jose-Mario Capo-Chichi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pathology|June 6, 2019
Emerging patterns in clonal haematopoiesisJose-Mario Capo-Chichi, Phillip Michaels, Rosemarie Tremblay-Le May, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell TransplantationGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Human Pathology|August 18, 2020
Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcomeGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Bioinformatics (Oxford, England)|February 12, 2022
SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived dataJessie J F Medeiros, Jose-Mario Capo-Chichi, Liran I Shlush, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
The Clinical Utility of <i>FLT3</i> Mutation Testing in Acute Leukemia: A Canadian ConsensusJulie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, et al.
The Journal of Pathology. Clinical Research|November 3, 2018
Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluationAoife J McCarthy, Jose-Mario Capo-Chichi, Tara Spence, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Plos Genetics|October 31, 2014
De novo mutations in moderate or severe intellectual disabilityFadi F Hamdan, Myriam Srour, Jose-Mario Capo-Chichi, et al.
Pageof 3